Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
EVR
|
Paul Pensa
Contr, Prin. Acct.Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 101 Reduced 0.57% |
$3,518
$34.83 p/Share
|
Feb 04
2011 |
EVR
|
Paul Pensa
Contr, Prin. Acct.Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,738 Added 8.91% |
-
|
Feb 04
2011 |
EVR
|
Robert B Walsh
Principal Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,494 Reduced 1.2% |
$52,036
$34.83 p/Share
|
Feb 04
2011 |
EVR
|
Robert B Walsh
Principal Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 14,358 Added 10.31% |
-
|
Feb 04
2011 |
EVR
|
Bernard J Taylor
Co-Vice Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 28,371 Added 27.08% |
-
|
Feb 04
2011 |
AMKR
|
James Mac Millan Fusaro
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 1,833 Reduced 9.17% |
$14,774
$8.06 p/Share
|
Feb 03
2011 |
AMKR
|
Gil C. Tily
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 2,291 Reduced 9.16% |
$18,465
$8.06 p/Share
|
Feb 03
2011 |
AMKR
|
Mike Lamble
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 2,104 Reduced 8.61% |
$16,958
$8.06 p/Share
|
Feb 03
2011 |
AMKR
|
Joanne Solomon
Executive VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,833 Reduced 8.06% |
$14,774
$8.06 p/Share
|
Feb 03
2011 |
BCPC
|
Joyce J. Lee |
BUY
Grant, award, or other acquisition
|
Direct | 590 Added 33.02% |
-
|
Feb 02
2011 |
NP
|
Sean T Erwin
Director |
SELL
Open market or private sale
|
Direct | 4,500 Reduced 100.0% |
$87,120
$19.36 p/Share
|
Feb 02
2011 |
NP
|
Sean T Erwin
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,200 Added 50.0% |
$16,302
$7.41 p/Share
|
Feb 02
2011 |
NP
|
Sean T Erwin
Director |
SELL
Open market or private sale
|
Direct | 6,500 Reduced 100.0% |
$125,515
$19.31 p/Share
|
Feb 01
2011 |
NP
|
Sean T Erwin
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 3,800 Added 50.0% |
$28,158
$7.41 p/Share
|
Feb 01
2011 |
NP
|
Sean T Erwin
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 5,400 Reduced 32.46% |
$104,868
$19.42 p/Share
|
Feb 01
2011 |
NP
|
Bonnie Cruickshank Lind
SVP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,928 Reduced 35.71% |
$37,442
$19.42 p/Share
|
Feb 01
2011 |
NP
|
John P O'Donnell
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,200 Reduced 35.03% |
$42,724
$19.42 p/Share
|
Feb 01
2011 |
NP
|
Dennis Runsten
Sr. V.P. & Pres Technical Prod |
SELL
Payment of exercise price or tax liability
|
Direct | 1,172 Reduced 36.67% |
$22,760
$19.42 p/Share
|
Feb 01
2011 |
NP
|
Julie Schertell
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,202 Reduced 36.68% |
$23,343
$19.42 p/Share
|
Feb 01
2011 |
NP
|
Steven S Heinrichs
SVP, General Counsel & Sec |
SELL
Payment of exercise price or tax liability
|
Direct | 1,293 Reduced 36.67% |
$25,110
$19.42 p/Share
|
Feb 01
2011 |
KWR
|
George H Hill |
SELL
Payment of exercise price or tax liability
|
Direct | 278 Reduced 6.47% |
$10,461
$37.63 p/Share
|
Jan 29
2011 |
KWR
|
D Jeffry Benoliel
VP - MW, Can and Mining |
BUY
Exercise of conversion of derivative security
|
Direct | 3,788 Added 5.71% |
$71,290
$18.82 p/Share
|
Jan 29
2011 |
KWR
|
D Jeffry Benoliel
VP - MW, Can and Mining |
SELL
Payment of exercise price or tax liability
|
Direct | 2,337 Reduced 3.71% |
$87,941
$37.63 p/Share
|
Jan 29
2011 |
KWR
|
Michael F Barry
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,100 Added 1.79% |
$14,553
$6.93 p/Share
|
Jan 29
2011 |
KWR
|
Michael F Barry
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 937 Reduced 0.82% |
$35,259
$37.63 p/Share
|
Jan 29
2011 |
KWR
|
Mark A Featherstone
VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 708 Reduced 4.46% |
$26,642
$37.63 p/Share
|
Jan 29
2011 |
MEI
|
Timothy Glandon
Vice President |
BUY
Open market or private purchase
|
Direct | 21 Added 0.02% |
$248
$11.79 p/Share
|
Jan 28
2011 |
KWR
|
Mark A Featherstone
VP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,000 Added 5.93% |
$6,930
$6.93 p/Share
|
Jan 28
2011 |
KWR
|
D Jeffry Benoliel
VP - MW, Can and Mining |
BUY
Bona fide gift
|
Indirect | 100 Added 1.0% |
-
|
Jan 27
2011 |
V
|
David I. Mc Kay
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,030 Added 12.9% |
-
|
Jan 27
2011 |
V
|
Peter Hawkins
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,030 Added 10.55% |
-
|
Jan 27
2011 |
V
|
Segismundo Schulin Zeuthen
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 182 Reduced 1.81% |
$12,849
$70.6 p/Share
|
Jan 27
2011 |
V
|
Segismundo Schulin Zeuthen
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,030 Added 16.81% |
-
|
Jan 27
2011 |
V
|
Hani Al Qadi
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 158 Reduced 7.78% |
$11,155
$70.6 p/Share
|
Jan 27
2011 |
V
|
Hani Al Qadi
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,872 Added 1.67% |
-
|
Jan 27
2011 |
V
|
Hani Al Qadi
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,030 Added 50.0% |
-
|
Jan 27
2011 |
V
|
Hani Al Qadi
Director |
SELL
Exercise of conversion of derivative security
|
Direct | 1,872 Reduced 100.0% |
-
|
Jan 27
2011 |
ATRX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 74,500 Reduced 2.9% |
$85,675
$1.15 p/Share
|
Jan 26
2011 |
AYI
|
Mark A Black
EVP |
SELL
Open market or private sale
|
Direct | 20,445 Reduced 34.39% |
$1,137,355
$55.63 p/Share
|
Jan 25
2011 |
ATRX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 93,005 Reduced 3.49% |
$106,026
$1.14 p/Share
|
Jan 25
2011 |
MDC
|
Vilia Valentine
PFO, PAO |
BUY
Grant, award, or other acquisition
|
Direct | 797 Added 22.0% |
-
|
Jan 25
2011 |
ATRX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 72,800 Reduced 2.66% |
$86,632
$1.19 p/Share
|
Jan 24
2011 |
ATRX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 69,500 Reduced 2.48% |
$88,265
$1.27 p/Share
|
Jan 21
2011 |
ATRX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 45,700 Reduced 1.6% |
$60,324
$1.32 p/Share
|
Jan 20
2011 |
ATRX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 5,700 Reduced 0.2% |
$8,436
$1.48 p/Share
|
Jan 20
2011 |
ATRX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 42,800 Reduced 1.48% |
$65,912
$1.54 p/Share
|
Jan 19
2011 |
MAS
|
William T Anderson
VP-Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 5,299 Reduced 3.93% |
$74,186
$14.0 p/Share
|
Jan 14
2011 |
MAS
|
Donald J De Marie Jr
Executive Vice President & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 11,083 Reduced 2.95% |
$155,162
$14.0 p/Share
|
Jan 14
2011 |
MAS
|
Charles F Greenwood
VP-Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct | 3,408 Reduced 4.02% |
$47,712
$14.0 p/Share
|
Jan 14
2011 |
MAS
|
Gregory Dale Wittrock
VP - General Counsel and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct | 2,546 Reduced 3.57% |
$35,644
$14.0 p/Share
|
Jan 14
2011 |